Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia
Open Access
- 6 November 2020
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 96 (2) , E52-E55
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA016672)
This publication has 6 references indexed in Scilit:
- Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular FeaturesBlood, 2019
- Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemiaLaboratory Investigation, 2017
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adultsBlood, 2015
- ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patientsLeukemia, 2014
- Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemiaBlood, 2013